In addition, several other identified targets, such as RET, FGFR3, NCAM1, TYMP, TNFRSF10B, MMP3, TACSTD2, and NOTCH2, were implicated in various cancers and present potential therapeutic avenues. Here, NCAM1 is linked to cancer.